92午夜免费无码国产电影大全_亚洲国产一级毛片久久久久_亚洲国产综合另类视频在线观看_国产区二幕区2021_又黄又爽免费视频_中文在线中文国产精品一_熟妇视频欧美熟妇另类视频_东京热精品97综合网_久久香蕉理论国产_亚洲AV永久无码导航

Main function

The center is ANEXT core technology platform which takes responsibility for innovative drug R&D and pilot, undertakes the company's new drug development and CDMO project research verification, system construction and R&D transformation work.

Scales

1000 square meters of high-standard GMP laboratory + Oriental Beauty Valley Institute of Regenerative Medicine academic platform.

location

Oriental Beauty Vally, Fengxian District, Shanghai.

Main function

ANEXT exosomes innovative medical device production base, declared and holds the medical device registration certificate and medical device production license, carrying the company's main medical device products scale production work.

Scales

3,000 square meters purification workshop, a full set of medical device production line, the subsequent proposed expansion of the scale of exosome material preparation function.

location

Tongcheng Economic and Technological Development Zone, Anqing City, Anhui Province.

Main function

Highly specific exosome engineering modification and screening laboratory, performing exosome modification, preparation, purification process testing and process validation, pilot production of exosome raw materials.

Scales

600 square meters GMP laboratory.

location

Jinan Bio Valley, Shandong Province.

Main function

Pilot and industrialization service platform for innovative medicines and biological pharmaceutical products, advanced technology production platform for sterile lyophilized powder injection (including liposome) preparations. Having MAH system services, OEM production, CDMO pilot, drug commissioned production, CMO contract production, drug cooperation declaration and clinical sample preparation.

Scales

A GMP certified (new version) lyophilized powder injection production line. Over 10,000 square meters of research and production facilities.

location

High-tech Zone, Chengdu, Sichuan Province.